JB
John P Brancaccio
Director

John P Brancaccio insider trades: OKYO Pharma (OKYO) stock buys and sales

Director, OKYO Pharma Last trade Jul 21, 2026 72 Form 4 filings
$0
Sold, last 12 months
0 sales
$7K
Bought, last 12 months
1 buy
12
Open-market trades
since 2006
11
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

and 5 more companies

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 21, 2026OKYO↑ Buy$7K
Sep 15, 2023OKYO↑ Buy$25K
Mar 22, 2021CRDF↑ Buy$33K
Dec 2, 2020HEPA↑ Buy$11K
May 14, 2020CRDF↑ Buy$10K
Jun 8, 2018TROV↑ Buy$8K
May 26, 2017SGYP↑ Buy$23K
Sep 19, 2016SGYP↓ Sell$15K
Jun 3, 2014SGYP↑ Buy$14K
Mar 4, 2014CTRV↑ Buy$7K
Oct 19, 2007ACEL↑ Buy$4K
Jul 24, 2006ACEL↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OKYO insiders

Open-market trades in the last 12 months

About John P Brancaccio's insider trades

John P Brancaccio is a director at OKYO Pharma (OKYO). Since Jul 24, 2006, John has reported 11 open-market purchases worth $151K and 1 sale worth $15K on SEC Form 4. In the last 12 months: 1 buy ($7K).

Their filings also include grants and awards (52 filings), option exercises (5 filings), other transactions (3 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OKYO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.